Literature DB >> 32016850

Angiotensin III induces p38 Mitogen-activated protein kinase leading to proliferation of vascular smooth muscle cells.

Ahmed Z Alanazi1,2, Michelle A Clark3.   

Abstract

BACKGROUND: Mitogen-activated protein kinases (MAPKs) are essential molecular transducers of extracellular stimuli into intracellular responses. MAPKs are crucial in mediating actions of the renin-angiotensin-aldosterone system (RAAS), in particular, functions mediated by Angiotensin (Ang) II, the main biological peptide produced by this system. We have shown that another biologically active heptapeptide Ang III also induces MAPKs in the central nervous system. The ability of Ang III to induce MAPKs in the periphery is unknown and was the focus of this study.
METHODS: We determined whether Ang III induced p38 MAPK in vascular smooth cells (VSMCs) isolated from Wistar and spontaneously hypertensive rats (SHRs) and compared these actions to those of Ang II. Further, the role of this MAPK in Ang III-mediated VSMC proliferation was also determined.
RESULTS: Both Ang peptides similarly induced p38 MAPK phosphorylation in VSMCs of Wistar VSMCs in a concentration- and time-dependent manner. SHR VSMCs were less sensitive to Ang III, which caused less of an effect on p38 MAPK phosphorylation in these cells. The Ang III effect was specific and occurred by activation of the Ang type 1 (AT1) receptor. The p38 MAPK pathway was also involved in Ang III-induced VSMC growth, as measured by DNA synthesis.
CONCLUSIONS: These findings suggest that the p38 MAPK signaling pathway is an important cascade in regulating the actions of Ang III in VSMCs. Most importantly, dysregulation of Ang III actions in these cells are apparent and may contribute to pathological conditions associated with dysfunctions in VSMCS.

Entities:  

Keywords:  Angiotensin III; Angiotensin type 1 receptor; Proliferation; Vascular smooth muscle cells; p38 MAPK

Mesh:

Substances:

Year:  2020        PMID: 32016850     DOI: 10.1007/s43440-019-00035-8

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  11 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 2.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

3.  Angiotensin III stimulates ERK1/2 mitogen-activated protein kinases and astrocyte growth in cultured rat astrocytes.

Authors:  Michelle A Clark; Hsieu Tran; Chinh Nguyen
Journal:  Neuropeptides       Date:  2011-07-23       Impact factor: 3.286

Review 4.  MAPK signal pathways in the regulation of cell proliferation in mammalian cells.

Authors:  Wei Zhang; Hui Tu Liu
Journal:  Cell Res       Date:  2002-03       Impact factor: 25.617

Review 5.  The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.

Authors:  Steven A Atlas
Journal:  J Manag Care Pharm       Date:  2007-10

Review 6.  Angiotensin III: a physiological relevant peptide of the renin angiotensin system.

Authors:  Vudhya G Yugandhar; Michelle A Clark
Journal:  Peptides       Date:  2013-05-18       Impact factor: 3.750

Review 7.  Classical Renin-Angiotensin system in kidney physiology.

Authors:  Matthew A Sparks; Steven D Crowley; Susan B Gurley; Maria Mirotsou; Thomas M Coffman
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 8.  STAT transcription in the ischemic heart.

Authors:  Richard A Knight; Tiziano M Scarabelli; Anastasis Stephanou
Journal:  JAKSTAT       Date:  2012-04-01

9.  The appropriate dose of angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?

Authors:  Junichi Ishida; Masaaki Konishi; Stephan von Haehling
Journal:  ESC Heart Fail       Date:  2015-11-17

10.  Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes.

Authors:  Michelle A Clark; Chinh Nguyen; Hieu Tran
Journal:  Int J Hypertens       Date:  2013-02-14       Impact factor: 2.420

View more
  4 in total

1.  Evening Primrose Extracts Inhibit PDGF-BB-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Regulating Cell-Cycle-Related Proteins.

Authors:  Jin-Ho Lee; Min Jeong Kim; Keun-Jung Woo; Joonpyo Hong; Sun-Hong Kim; Tack-Joong Kim
Journal:  Curr Issues Mol Biol       Date:  2022-04-27       Impact factor: 2.976

2.  Chromosome 2 Fragment Substitutions in Dahl Salt-Sensitive Rats and RNA Sequencing Identified Enpep and Hs2st1 as Vascular Inflammatory Modulators.

Authors:  Olga Berillo; Sofiane Ouerd; Noureddine Idris-Khodja; Asia Rehman; Chantal Richer; Daniel Sinnett; Anne E Kwitek; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2020-11-09       Impact factor: 10.190

3.  Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease.

Authors:  Éva Larouche-Lebel; Kerry A Loughran; Terry Huh; Mark A Oyama
Journal:  J Vet Intern Med       Date:  2020-12-24       Impact factor: 3.175

4.  Intrarenal Renin Angiotensin System Imbalance During Postnatal Life Is Associated With Increased Microvascular Density in the Mature Kidney.

Authors:  Carolina Dalmasso; Alejandro R Chade; Mariela Mendez; Jorge F Giani; Gregory J Bix; Kuey C Chen; Analia S Loria
Journal:  Front Physiol       Date:  2020-09-01       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.